The difference in surface phenotypes between cytotoxic lymphocytes induced in vivo by systemic administration of human recombinant interleukin-2 and lymphokine activated killer cells induced in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/3261691

Download in:

View as

General Info

PMID
3261691